Pharmacological Effects of a Specific Leukotriene B4 Receptor Antagonist (VML 295) on Blood Leukocytes, Cutaneous Inflammation and Epidermal Proliferation.

Autor: Seegers, Bianca A.M.P.A., Andriessen, Monique P.M., van Hooijdonk, Candida A.E.M., de Bakker, Els S.M., van Vlijmen-Willems, Ivonne M.J.J., Parker, Gerry L., van Erp, Piet E.J., van de Kerkhof, Peter C.M.
Zdroj: Skin Pharmacology & Applied Skin Physiology; 2000, Vol. 13 Issue 2, p75-85, 11p
Databáze: Complementary Index